We are live on ! Find out more
GCM

Geneva Capital Management Portfolio holdings

AUM $4.36B
1-Year Est. Return 17.81%
This Fund
S&P 500
This Quarter Est. Return
-0.4%
1 Year Est. Return
+17.81%
3 Year Est. Return
+59.44%
5 Year Est. Return
+75.65%
10 Year Est. Return
AUM
$4.33B
AUM Growth
-$15.9M
Cap. Flow
+$139M
Cap. Flow %
3.22%
Top 10 Hldgs %
24.98%
Holding
130
New
2
Increased
58
Reduced
68
Closed
2

Top Buys

Rank Stock Value
1
CERT icon
Certara
CERT
+$21.6M
2
MLAB icon
Mesa Laboratories
MLAB
+$19.1M
3
OMCL icon
Omnicell
OMCL
+$13.1M
4
PLUS icon
ePlus
PLUS
+$9.74M
5
NVEE
NV5 Global
NVEE
+$9.45M

Sector Composition

Rank Sector Weight
1 Technology 33.64%
2 Industrials 25.88%
3 Healthcare 17.08%
4 Consumer Discretionary 8.12%
5 Financials 7.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CSGP icon
51
CoStar Group
CSGP
$12.3B
$35M 0.81%
502,119
-7,929
-2% -$550K
BFAM icon
52
Bright Horizons
BFAM
$3.86B
$34.3M 0.79%
594,461
+24,196
+4% +$1.84M
AX icon
53
Axos Financial
AX
$5.68B
$32.7M 0.76%
955,501
+36,383
+4% +$1.47M
AZTA icon
54
Azenta
AZTA
$1.48B
$31.9M 0.74%
745,332
+29,070
+4% +$1.74M
WDFC icon
55
WD-40
WDFC
$3.15B
$31.3M 0.72%
178,242
+6,675
+4% +$1.25M
BLKB icon
56
Blackbaud
BLKB
$2.08B
$31.1M 0.72%
705,820
+25,955
+4% +$1.4M
IEX icon
57
IDEX
IEX
$17.3B
$30.5M 0.7%
152,612
-2,922
-2% -$591K
IT icon
58
Gartner
IT
$11.7B
$29.9M 0.69%
107,944
-2,564
-2% -$719K
PLMR icon
59
Palomar
PLMR
$3.45B
$28.9M 0.67%
344,811
+12,448
+4% +$914K
EPAM icon
60
EPAM Systems
EPAM
$5.03B
$28.8M 0.66%
79,405
-1,393
-2% -$533K
AXON
61
Axon Enterprise
AXON
$46.4B
$28.4M 0.66%
245,200
-1,457
-0.6% -$165K
CDMO
62
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$27.5M 0.64%
1,440,364
+74,014
+5% +$1.35M
FISV
63
Fiserv Inc
FISV
$27.9B
$26.6M 0.61%
283,990
-5,968
-2% -$608K
RGEN icon
64
Repligen
RGEN
$9.25B
$26.5M 0.61%
141,413
-1,996
-1% -$421K
ALGT icon
65
Allegiant Air
ALGT
$2.57B
$26.4M 0.61%
361,915
+13,355
+4% +$1.38M
QTWO icon
66
Q2 Holdings
QTWO
$3.92B
$24.7M 0.57%
768,164
+42,212
+6% +$1.72M
ULTA icon
67
Ulta Beauty
ULTA
$24.3B
$23.8M 0.55%
59,409
-1,091
-2% -$439K
VRSK icon
68
Verisk Analytics
VRSK
$25B
$22.9M 0.53%
134,026
-3,122
-2% -$584K
STE icon
69
Steris
STE
$23.1B
$22.8M 0.53%
137,098
-3,173
-2% -$646K
IDXX icon
70
Idexx Laboratories
IDXX
$46.2B
$22.8M 0.53%
69,937
-1,661
-2% -$610K
RJF icon
71
Raymond James Financial
RJF
$34B
$22.7M 0.52%
229,931
-4,419
-2% -$447K
ANSS
72
DELISTED
Ansys
ANSS
$22.6M 0.52%
101,809
-2,311
-2% -$591K
NEOG icon
73
Neogen
NEOG
$2.5B
$22.5M 0.52%
1,607,224
+67,322
+4% +$1.36M
BR icon
74
Broadridge
BR
$19B
$22.3M 0.52%
154,782
-3,878
-2% -$629K
ABMD
75
DELISTED
Abiomed Inc
ABMD
$21.9M 0.51%
89,179
-1,247
-1% -$337K

Similar funds

Geneva Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Geneva Capital Management held 130 positions worth $4.33B, down 0.37% from $4.35B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Geneva Capital Management deployed $139M of net new capital in Q3 2022, opening 2 new positions and adding to 58 existing holdings. Its largest new stake was Certara: 1,170,270 shares worth $15.5M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 34% a quarter earlier, followed by Industrials and Healthcare.

On the sell side, the largest reduction was LHC Group LLC, an estimated $39.4M trimmed.

  • Geneva Capital Management's largest Q3 2022 buy was Certara: 1,170,270 shares worth $15.5M.
  • Geneva Capital Management added most to Omnicell in Q3 2022, an estimated $13.1M increase.
  • Geneva Capital Management's biggest Q3 2022 reduction was LHC Group LLC, cutting an estimated $39.4M.
  • Geneva Capital Management fully exited VF Corp in Q3 2022, selling an estimated $823K.
  • Geneva Capital Management's ten largest holdings make up 25% of its $4.33B portfolio in Q3 2022.
  • Geneva Capital Management opened 2 new positions and closed 2 in Q3 2022.
  • Geneva Capital Management's portfolio value fell 0.37% quarter-over-quarter to $4.33B.

Based on Geneva Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.